Assessment of the 1p/19q Deletions at Different Areas in Biphasic Oligoastrocytomas by Using Chromogenic In Situ Hybridization

被引：0
|
作者：
Oliveira, V. C. [1 ]
Carrara, R. C. V. [1 ]
Covas, D. T. [1 ]
Latorraca, E. F. [1 ]
Carlotti, C. G. [1 ]
Colli, B. O. [1 ]
Machado, H. R. [1 ]
Neder, L. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1510
引用
收藏
页码：333A / 333A
页数：1
相关论文
共 50 条
  • [31] Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component
    Takeuchi, Hiroaki
    Kubota, Toshihiko
    Kitai, Ryuhei
    Matsuda, Ken
    Hashimoto, Norichika
    Sato, Kazufumi
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (01) : 33 - 38
  • [32] Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization
    Jongmin Sim
    Do-Hyun Nam
    Yuil Kim
    In-Hee Lee
    Jung Won Choi
    Jason K. Sa
    Yeon-Lim Suh
    Medical Oncology, 2018, 35
  • [33] DNA extraction by FTA™ technology:: application for rapid detection of 1p/19q deletions in gliomas
    Fontaine, D.
    Monnot, S.
    Vandenbos, F.
    Paquis, P.
    Michiels, J.-F.
    Bannwarth, S.
    Paquis-Flucklinger, V.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (03) : 360 - 363
  • [34] A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q in human oligodendrogliomas.
    Jenkins, Robert B.
    Blair, Hilary
    Flynn, Heather
    Passe, Sandra
    Law, Mark
    Ballman, Karla V.
    Aldape, Ken
    Giannini, Caterina
    Buckner, Jan C.
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Fluorescent In Situ Hybridization 1p/19q Deletion/Imbalance Analysis of Low-Grade and Atypical Meningiomas Commentary
    Bao, Shengde
    NEUROLOGIA MEDICO-CHIRURGICA, 2010, 50 (01) : 32 - 32
  • [36] Heterogeneity of molecular genetic alterations in oligodendrogliomas and mixed oligoastrocytomas: Correlation of 1p, 19q and PTEN loss with patient prognosis
    Scheck, AC
    Pueschel, JK
    Ashby, LS
    Coons, SW
    Shapiro, WR
    NEURO-ONCOLOGY, 2004, 6 (04) : 354 - 354
  • [37] ImmunoFISH is a Reliable Technique for the Assessment of 1p and 19q Status in Oligodendrogliomas.
    Gould, Peter
    Duval, Celine
    de Tayrac, Marie
    Sanschagrin, Francois
    Michaud, Karine
    Saikali, Stephan
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 632 - 632
  • [38] Absence of 1p/19q codeletion in oligodendroglioma-like areas of pilocytic astrocytomas
    Frazer, Beth
    Kearney, Hugh
    Cryan, Jane
    Beausang, Alan
    Brett, Francesca
    Farrell, Michael A.
    Buckley, Patrick G.
    CLINICAL NEUROPATHOLOGY, 2018, 37 (04) : 182 - 185
  • [39] Oligodendrogliomas: relation of morphology to 1p/19q genotype
    An, S.
    Henriquez, N.
    Puls, F.
    Brandner, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 11 - 12
  • [40] Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji, Macoura
    Fortin, David
    Tsanaclis, Ana-Maria
    Drouin, Regen
    CANCER GENETICS AND CYTOGENETICS, 2009, 194 (01) : 12 - 22
12345